M. P. Rudolf, J. D. Nieland, D. M. DaSilva, M. P. Velders, M. Müller, H. L. Greenstone, J. T. Schiller, W. M. Kast
Induction of HPV16 Capsid Protein-Specific Human T Cell
Responses by Virus-Like Particles
It has been postulated that upon binding to a cell
surface receptor, papilloma virus-like particles (VLPs)
gain entry into the cytosol of infected cells and the
capsid proteins L1 and L2 can be processed in the
MHC class I presentation pathway. Vaccination of
mice with human papilloma virus-like particles consisting
of capsid proteins L1 and L2 induced a CD8-
mediated and perforin dependent protective immune
response against a tumor challenge with human papilloma
virus transformed tumor cells, which express
only minute amounts of L1 protein. Here we show that
HPV16 capsid proteins stimulate a MHC class I restricted
CTL response with human peripheral blood
lymphocytes (PBL) in vitro. The vigorous response
was specific for VLP-infected target cells and was
MHC class I restricted. Moreover we show the presence
of at least one HLA-A*0201 restricted CTL epitope
within the HPV-16 capsid proteins by using a VLP-‘infected’ HLA-A*0201 transfected human cell line as
target cells. These results demonstrated that VLPs
can induce a HPV16 capsid protein-specific immune
response in humans, allowing the monitoring of
immune responses induced by vaccines based on
chimeric VLPs carrying additional immunogenic peptides
or proteins in therapeutical applications in human
patients.
Biological Chemistry, Walter de Gruyter
Print ISSN: 1431-6730
Volume: 380, 03/1999
Pages: 335 - 340
Show full article (external site)
Show all available items of this journal